NVO · Novo Nordisk
AI read · Good for NVO
The AI's read
The findings add evidence that CagriSema may help people lose weight, alongside reports of fewer food-related thoughts among Wegovy users. This supports Novo Nordisk’s obesity drug business. CagriSema still awaits a U.S. decision, and trials have not established its safety and effectiveness.